Major medical groups issue independent fall vaccine guidance
Doctors move to fill federal advisory gap
Four leading U.S. medical organizations have issued independent recommendations for the 2026-2027 respiratory virus season, providing guidance on influenza, COVID-19, and RSV vaccinations after delays in updated federal recommendations. The joint guidance was released by the American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College of Obstetricians and Gynecologists (ACOG), and the Infectious Diseases Society of America (IDSA) to help physicians and patients prepare for the upcoming fall and winter virus season.
The organizations recommend an annual influenza vaccine for nearly everyone 6 months of age and older, with enhanced formulations for many adults 65 and older. For COVID-19, they recommend updated seasonal vaccination for adults 19 and older, while advising older adults and people with weakened immune systems to receive an additional dose approximately six months after their first seasonal vaccination when appropriate. The guidance also recommends RSV vaccination for adults 75 and older, adults 50 to 74 who have qualifying medical conditions, and pregnant patients between 32 and 36 weeks of pregnancy to help protect newborns during their first months of life.
The recommendations were published in the Journal of the American Medical Association (JAMA) after the Centers for Disease Control and Prevention (CDC) had not finalized updated guidance for the season. The organizations said clinicians needed timely recommendations before vaccination campaigns begin nationwide. The guidance draws on evidence reviewed through the University of Minnesota's Vaccine Integrity Project, which examined thousands of scientific studies and concluded that current evidence continues to support the safety and effectiveness of recommended seasonal vaccines for eligible populations.
The medical societies emphasized that their recommendations are intended to provide practical clinical guidance while federal advisory processes continue. Physicians and patients are encouraged to discuss individual health conditions, age, pregnancy status, and underlying medical risks when deciding which seasonal vaccines are appropriate before respiratory viruses become more widespread later this year.